Spots Global Cancer Trial Database for Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer
Official Title: A Randomized Phase II Trial of Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer Eligible for Platinum-based Chemotherapy. Supported by: DIAGNOSTIC PROTOCOL for the VENTANA FOLR1 (FOLR1-2.1) CDx Assay Ventana No. RD004881; Protocol Document No. D152967
Study ID: NCT04274426
Study Description
Brief Summary: This is a multi-center, randomized, two-arm, open-label, comparative phase II trial of Mirvetuximab soravtansine (IMGN853), in folate receptor alpha (FRα) high recurrent ovarian cancer eligible for platinum-based chemotherapy.
Detailed Description: 136 patients will be randomized into the follow-ing two treatment arms as specified below: Arm A: Control arm Platinum-based chemotherapy Arm B: Carboplatin + Mirvetuximab soravtansine (IMGN853)
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Charite Campus Virchow Klinikum, Berlin, , Germany
Städtische Klinikum Dessau, Dessau, , Germany
Universitätsklinikum Carl-Gustav-Carus an der Technischen Universität Dresden, Dresden, , Germany
Universitätsklinikum Düsseldorf, Düsseldorf, , Germany
Evangelische Kliniken-Essen-Mitte, Essen, , Germany
Universitätsklinikum Frankfurt, Frankfurt, , Germany
Universitätsklinikum Hamburg Eppendorf, Hamburg, , Germany
Medizinische Hochschule Hannover, Hannover, , Germany
ViDia Christliche Kliniken Karlsruhe, Karlsruhe, , Germany
HELIOS Klinikum Krefeld, Krefeld, , Germany
St. Elisabeth-Krankenhaus GmbH, Köln-Hohenlind, , Germany
Klinikum Mannheim, Mannheim, , Germany
OnkoNet Marburg, Marburg, , Germany
Klinikum der Universität München, München, , Germany
Rotkreuzklinikum München, München, , Germany
TU München, Klinikum recht der Isar, München, , Germany
Universitätsklinik Münster, Münster, , Germany
Klinikum Südstadt Rostock, Rostock, , Germany
Universitätsfrauenklinik Ulm, Ulm, , Germany
Contact Details
Name: Philipp Harter
Affiliation: Kliniken Essen-Mitte, Germany
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
